Howard P Scher Deceased7560 NW 75Th Dr, Parkland, FL 33067

Howard Scher Phones & Addresses

7560 75Th St, Parkland, FL 33067 954-3453836

7560 75Th Dr, Pompano Beach, FL 33067 954-3453836

Coconut Creek, FL

Dix Hills, NY

Lake Butler, FL

Get Report

Control this profile

Mentions for Howard P Scher

Career records & work history

Medicine Doctors

Howard I. Scher

Specialties:

Urology, Medical Oncology

Work:

Memorial Sloan Kettering Cancer Center Urology
353 E 68 St, New York, NY 10065
646-4224329 (phone) 212-9880759 (fax)

Education:

Medical School
New York University School of Medicine
Graduated: 1976

Procedures:

Chemotherapy

Conditions:

Prostate Cancer, Acute Renal Failure, Anemia, Anxiety Dissociative and Somatoform Disorders, Bacterial Pneumonia, Bladder Cancer, Chronic Renal Disease, Diabetes Mellitus (DM), Erectile Dysfunction (ED), Intestinal Obstruction, Kidney Cancer, Liver Cancer, Malignant Neoplasm of Colon, Melanoma, Ovarian Cancer, Pneumonia, Testicular Cancer, Thyroid Cancer, Venous Embolism and Thrombosis

Languages:

English

Description:

Dr. Scher graduated from the New York University School of Medicine in 1976. He works in New York, NY and specializes in Urology and Medical Oncology. Dr. Scher is affiliated with Memorial Sloan Kettering Cancer Center.

Howard Scher videos

Youtube

The History Of Biomarkers In The Treatment Of Prostate Cancer

Duration:

3m 43s

Description:

Howard Scher, MD, FASCO, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses biomarkers associated with poor...

Dr. Howard Scher On Key Findings From The Cou-Aa-302 Trial

Duration:

1m 46s

Description:

Howard I. Scher, MD, Chief of the Genitourinary Oncology Service at the Sidney Kimmel Center for Prostate and Urologic Cancers...

Dr. Howard Scher, Md

Duration:

3m 21s

Description:

Dr_Howard_Scher_...

Dr. Howard Scher On Corticosteroids During Treatment With Enzalutamide In Mcrpc

Duration:

1m 39s

Description:

Howard I. Scher, MD, Chief of the Genitourinary Oncology Service at the Sidney Kimmel Center for Prostate and Urologic Cancers...

Dr. Howard Scher On Findings From The Cou-Aa-302 Trial

Duration:

2m 8s

Description:

Howard I. Scher, MD, Chief of the Genitourinary Oncology Service at the Sidney Kimmel Center for Prostate and Urologic Cancers...

Dr. Howard Scher On Concomitant Corticosteroid Use In The Affirm Trial

Duration:

2m 43s

Description:

Howard I. Scher, MD, Chief of the Genitourinary Oncology Service at the Sidney Kimmel Center for Prostate and Urologic Cancers...

Flickr

In the News

News

New Cancer Drugs Alectinib And Abiraterone May Help Lung And Prostate Disease Patients Live Longer

Date:

Jun 05, 2017

Category:

Health

Source:

Newsweek

"The implications are global," says Howard Scher, who treatsprostate cancer at Memorial Sloan-Kettering Cancer Center and was not involved in the study. Among the next steps, he says, is research to understand "which of these two alternatives will provide the best outcome for the individual patient

Test Aids Prostate Cancer Treatment

Date:

Jul 07, 2016

Category:

Health

Source:

Fox News

If AR-V7 was present, the patients didnt respond to the [new] agents, said Howard Scher, chief of genitourinary oncology at Memorial Sloan-Kettering Cancer Center, New York. They progressed more quickly and they didnt live as long as those treated with chemo. Dr. Scher is lead author of the st

Aspirin Might Be The New Hope For Prostate Cancer Patients

Date:

Jan 06, 2016

Category:

Health

Source:

Pulse Headlines

er cells into the bloodstream. The test could help determine the best treatments for prostate cancer patients by using a computer to analyze the look of those cells, according to lead author Dr. Howard Scher, head of the Genitourinary Oncology Service at Memorial Kettering Cancer Center in New York.

Aspirin May Decrease Death From Prostate Cancer, Study Finds

Date:

Jan 05, 2016

Category:

Health

Source:

HealthDay

Solid tumors shed cancer cells into the bloodstream. This test uses a computer to analyze the appearance of those cells, said lead researcher Dr. Howard Scher, chief of the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center in New York City.

Medivation Surges On Prostate Cancer Drug: San Francisco Mover

Date:

Feb 01, 2012

Category:

Health

Source:

BusinessWeek

It's a big deal when you see this kind of survival benefit with a pill that doesn't have a lot of side effects, said Howard Scher, co-principal investigator on the trial and head of genitourinary oncology at Memorial Sloan-Kettering Cancer Center in New York, by telephone. This trial exceeded its

Medivation Prostate Cancer Drug Well-Tolerated In Trial

Date:

Feb 01, 2012

Category:

Health

Source:

Fox News

Five patients, or 0.6 percent of the treated group, experienced seizures, said Dr. Howard Scher of Memorial Sloan-Kettering Cancer Center in New York, the trial's lead investigator. An earlier trial of MDV3100 found that 1.5 percent of 198 treated patients had seizures, and some observers were conce

Gaining On Prostate Cancer

Date:

Feb 01, 2012

Category:

Health

Source:

Wall Street Journal

Howard Scher, a veteran of prostate-cancer studies and chief of the genitourinary oncology service at Memorial Sloan-Kettering Cancer, agreed to run the research, which began in 2007. Aided by a 13-center research consortium group funded by the Defense Department and the Prostate Cancer Foundation a

Study Shows Benefit Of J&J Prostate Cancer Drug

Date:

Jun 04, 2011

Category:

Health

Source:

Wall Street Journal

screened with a test for prostate-specific antigen, or PSA. But that measure can be deceiving, sometimes rising even when a patient is benefiting from a treatment, and vice versa, according to Howard Scher, chief of the Genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Center in New York.

Publications & IP owners

Us Patents

Inhibitor-Functionalized Ultrasmall Nanoparticles And Methods Thereof

US Patent:

2019028, Sep 19, 2019

Filed:

Nov 29, 2017

Appl. No.:

16/463865

Inventors:

- New York NY, US
- Ithaca NY, US
- Columbia MO, US
Wolfgang Weber - Larchmont NY, US
Karim Touijer - New York NY, US
Howard Scher - Tenafly NJ, US
Kai Ma - Ithaca NY, US
Ulrich Wiesner - Ithaca NY, US

International Classification:

A61K 49/00
A61K 51/08
A61K 51/12
C07K 7/02

Abstract:

Described herein are novel conjugates containing an inhibitor (e.g., a PSMA inhibitor, e.g., a gastrin-releasing peptide receptor inhibitor) and metal chelator that are covalently attached to a macromolecule (e.g., a nanoparticle, a polymer, a protein). Such conjugates exhibit distinct properties over the free, unbound inhibitor/chelator construct.

Isbn (Books And Publications)

Principles And Practice Of Genitourinary Oncology

Author:

Howard I. Scher

ISBN #:

0397514581

Neoadjuvant Chemotherapy In Invasive Bladder Cancer: Proceedings Of An International Workshop Held In San Francisco, May 19-20, 1989

Author:

Howard I. Scher

ISBN #:

0471568171

Possible Relatives

David L Scher Daniel C Scher Eli D Scher Elizabeth A Scher Eric S Scher Frank A Scher Gail B Scher Howard T Johnson Howard F Standen Howard K Standley

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.